Research Focus

Research and Technology Management; Senior Manager, Study Start Up (Sr PAM)

Recent additions – View all

1. Durable clinical outcomes in patients (pts) with advanced melanoma and progression-free survival (PFS) ≥3y on nivolumab (NIVO) ± ipilimumab (IPI) or IPI in checkmate 067

   Meeting Abstract

   Hodi, F. S.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Rutkowski, P.; Lao, C. D.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
   Journal of Clinical Oncology (2023)

   Fulltext@MSK | Save
2. A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumors

   Journal Article

   Monk, J. P.; Villalona-Calero, M.; Larkin, J.; Otterson, G.; Spriggs, D.; Hannah, A. L.; Cropp, G. F.; Johnson, R. G.; Hensley, M. L.
   Investigational New Drugs (2012)

   Fulltext@MSK | Save
3. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study

   Journal Article

   Hensley, M. L.; Ishill, N.; Soslow, R.; Larkin, J.; Abu Rustum, N.; Sabbatini, P.; Konner, J.; Tew, W.; Spriggs, D.; Aghajanian, C. A.
   Gynecologic Oncology (2009)

   Fulltext@MSK | Save